Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of postoperative hypoparathyroidism on bone density.

L M Hurxthal, W E Dotter, G P Vose

    Texas Reports on Biology and Medicine
    |January 1, 1976
    PubMed
    Summary

    Permanent hypoparathyroidism is linked to higher vertebral bone density, especially with thyroid hormone treatment. Transient hypoparathyroidism shows normal density, with no clear link to thyroid treatment duration.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Renal function and major surgery.

    The Surgical clinics of North America·2010
    Same author

    Cretinism.

    The American journal of medicine·2010
    Same author

    Proportional dwarfism with delayed sexual maturity; apparent response to desiccated thyroid.

    The Lahey Clinic bulletin·2010
    Same author

    Treatment of resistant paroxysmal auricular tachycardia with prostigmine followed by mecholyl.

    The Lahey Clinic bulletin·2010
    Same author

    Pituitary tumor.

    The Surgical clinics of North America·2010
    Same author

    Eunuchoidism with excessive urinary 17-ketosteroids and response to testosterone therapy.

    The Lahey Clinic bulletin·2010

    Area of Science:

    • Endocrinology
    • Bone Metabolism
    • Radiology

    Background:

    • Hypoparathyroidism can affect bone mineral density.
    • Thyroid hormone replacement therapy is sometimes used in patients with hypoparathyroidism.
    • The relationship between hypoparathyroidism, thyroid treatment, and vertebral density requires further investigation.

    Purpose of the Study:

    • To investigate vertebral bone density in patients with permanent and transient hypoparathyroidism.
    • To assess the impact of desiccated thyroid treatment on vertebral density in these patients.
    • To explore the correlation between thyroid treatment duration and vertebral density.

    Main Methods:

    • Radiographic assessment of vertebral bone density.
    • Comparison of bone density between hypoparathyroid patients (permanent and transient) and controls.
    • Analysis of bone density in patients receiving desiccated thyroid extract.
    • Correlation analysis between duration of thyroid treatment and vertebral density.

    Main Results:

    • Permanently hypoparathyroid patients exhibited elevated vertebral density compared to age-matched controls.
    • Patients with transient hypoparathyroidism had normal vertebral density.
    • Both transient and permanent hypoparathyroid patients on desiccated thyroid showed significantly higher vertebral densities.
    • A positive correlation was observed between the duration of thyroid treatment and vertebral hypermineralization in permanent hypoparathyroidism and hypothyroidism.
    • No significant correlation was found between thyroid treatment duration and vertebral density in transient hypoparathyroidism.
    • No significant differences in vertebral compression incidence were noted between hypoparathyroid patients and controls.
    • Calcium and vitamin D treatment normalized blood calcium levels in transient and permanent hypoparathyroid patients, unlike untreated permanent hypoparathyroid patients.

    Conclusions:

    • Vertebral bone density is elevated in permanent hypoparathyroidism, particularly with thyroid hormone therapy.
    • Transient hypoparathyroidism does not appear to affect vertebral bone density.
    • Thyroid hormone replacement may contribute to increased bone mineral density in hypoparathyroid patients.
    • Effective management of hypoparathyroidism with calcium and vitamin D is crucial for normalizing calcium levels.

    Related Experiment Videos